Preimplantation Genetics Diagnosis Industry Demand

• Cost-effectiveness: By allowing for the selection of genetically viable embryos, PGD reduces the need for multiple IVF cycles, ultimately lowering overall treatment costs.
• Ease of administration: As an adjunct to IVF, PGD has become more streamlined and less invasive due to innovations in embryo biopsy and genetic analysis.
• Long shelf life of genetic materials: Improved storage technologies for genetic samples and embryos enhance the feasibility of PGD over extended periods, supporting treatment planning and flexibility.

Preimplantation Genetics Diagnosis Market: Growth Drivers & Key Restraint Growth Drivers –

• Technological Advancements in Genetic Testing

• Rising Prevalence of Genetic and Chronic Disorders

• Increase in Outsourcing and Fertility Tourism

Restraint –

• Ethical and Legal Concerns

Preimplantation Genetics Diagnosis Market: Segment Analysis Segment Analysis by Technology–

• Next-Generation Sequencing (NGS): Widely regarded as the most transformative technology in the PGD market, NGS offers high-throughput and precise chromosomal analysis, making it the preferred choice for advanced PGD applications.
• Polymerase Chain Reaction (PCR): Known for its precision, PCR is widely used to detect single-gene disorders. Its rapid results and cost-efficiency make it a reliable option, particularly in emerging markets.
• Fluorescence In Situ Hybridization (FISH): Although gradually being replaced by newer technologies, FISH is still relevant in detecting specific chromosomal abnormalities.
• Comparative Genomic Hybridization (CGH): Continues to be a reliable method for detecting chromosomal abnormalities. It's often employed when multiple chromosomal regions require simultaneous screening.

Segment Analysis by Test Type–

• Aneuploidy Screening: This is the most commonly performed test, especially for patients of advanced maternal age. Its widespread use is driven by its association with increased implantation success rates.
• Structural Chromosomal Abnormalities: This segment focuses on translocations, deletions, or duplications. It plays a vital role for couples with identified chromosomal rearrangements.
• Single Gene Disorders: High demand stems from families with a history of conditions like cystic fibrosis or sickle cell anemia. The precision of PGD in these cases significantly reduces recurrence risk.
• HLA Typing: Although niche, HLA typing is growing in demand for families seeking tissue matches for existing children requiring transplants.

• Gender Selection: A controversial yet growing application, mainly in regions where sex- linked diseases are a concern or where cultural preferences exist.

Segment Analysis by Application –

• Single Gene Disorders (e.g., Cystic Fibrosis): These applications demonstrate significant clinical impact, offering families a chance to prevent life-threatening hereditary diseases.
• Aneuploidy: The largest application, primarily due to its role in improving IVF success rates and reducing miscarriages.
• X-linked Gene Disorders: Particularly relevant for families where genetic mutations are passed through maternal chromosomes.
• Chromosomal Abnormalities: PGD applications here focus on avoiding conditions like Down syndrome, which are often linked to maternal age.
• HLA Typing & Gender Selection: Though controversial, these applications are expanding as technology enables more precise and safe embryo selection.

Preimplantation Genetics Diagnosis Market: Regional Insights

Europe:

Asia-Pacific (APAC):

Top Players in the Preimplantation Genetics Diagnosis Market